Literature DB >> 18792144

Handling of the TEMPO+ behind-the-ear speech processor by MED-EL cochlear implant users.

Ilona Anderson1, Marcus Schmidt, Thomas Buchreiter, Kristin Bisanar.   

Abstract

MED-EL launched its ear-level speech processor, the TEMPO+, in 1999. Studies have already demonstrated improved speech perception, sound quality and the ability to enjoy music with the TEMPO+ due to the new CIS+ speech-coding strategy. This study evaluated responses to 185 questionnaires about ease of handling and usage of the TEMPO+, opinion of and satisfaction with the TEMPO+ and its performance, as well as satisfaction with accessories. There was particular interest in seeing if the TEMPO+ was suitable for use with children. Results showed that MED-EL cochlear implant users felt comfortable manipulating the dials and switches, changing the battery pack, using external sources of input and with provided accessories. Overall, there was satisfaction with the TEMPO+. Notably, one third of respondents were under the age of 10. Results show the suitability of the TEMPO+ behind-the-ear speech processor for young children.

Entities:  

Year:  2003        PMID: 18792144     DOI: 10.1179/cim.2003.4.3.110

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  2 in total

1.  Multicentre Evaluation of the Naída CI Q70 Sound Processor: Feedback from Cochlear Implant Users and Professionals.

Authors:  Jeanette Martin; Christine Poncet-Wallet; Angelika Illg; Sarah Perrin-Webb; Lise Henderson; Nathalie Noël-Petroff; Gennaro Auletta; Maria Grazia Barezzani; Karim Houri; Heike Bagus; Ulrich Hoppe; Jane Humphries; Wiebke van Treeck; Jeroen J Briaire; Martina Brendel; Nathalie Mathias
Journal:  Audiol Res       Date:  2016-12-22

2.  Psychometric properties of the English version of the Audio Processor Satisfaction Questionnaire (APSQ).

Authors:  Jenna Felder; Edda Amann; Ilona Anderson; Joshua Stohl; Mareike Billinger-Finke
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.